Clinical Trial Update: Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety and immunogenicity of artificial Invaplex for Shigella flexneri 2a; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacillary Dysentery
• Shigellosis

Drugs mentioned

• Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) (InvaplexAR)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Shigellosis, Bacillary Dysentery | Phase 1 | Status: COMPLETED | Results posted: 2020-07-22